ATE478964T1 - Sonde zur diagnose von marfans-syndrom sowie verfahren zum screening mit der sonde - Google Patents

Sonde zur diagnose von marfans-syndrom sowie verfahren zum screening mit der sonde

Info

Publication number
ATE478964T1
ATE478964T1 AT05745933T AT05745933T ATE478964T1 AT E478964 T1 ATE478964 T1 AT E478964T1 AT 05745933 T AT05745933 T AT 05745933T AT 05745933 T AT05745933 T AT 05745933T AT E478964 T1 ATE478964 T1 AT E478964T1
Authority
AT
Austria
Prior art keywords
probe
screening
diagnosing
nucleic acid
marfan syndrome
Prior art date
Application number
AT05745933T
Other languages
English (en)
Inventor
Norio Niikawa
Naomichi Matsumoto
Catherine Boileau
Gwenaielle Beroud
Guillaume Jondeau
Original Assignee
Univ Nagasaki
Inst Nat Sante Rech Med
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Nagasaki, Inst Nat Sante Rech Med filed Critical Univ Nagasaki
Application granted granted Critical
Publication of ATE478964T1 publication Critical patent/ATE478964T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Wood Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physics & Mathematics (AREA)
  • General Engineering & Computer Science (AREA)
  • Toxicology (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Biotechnology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pathology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Biomedical Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Peptides Or Proteins (AREA)
  • Techniques For Improving Reliability Of Storages (AREA)
  • Testing Of Individual Semiconductor Devices (AREA)
AT05745933T 2004-05-27 2005-05-27 Sonde zur diagnose von marfans-syndrom sowie verfahren zum screening mit der sonde ATE478964T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2004158099A JP4706193B2 (ja) 2004-05-27 2004-05-27 マルファン症候群の分析のためのプローブの使用、スクリーニング方法およびキット
PCT/JP2005/010213 WO2005116253A1 (ja) 2004-05-27 2005-05-27 マルファン症候群診断用プローブ、及び当該プローブを用いたスクリーニング法

Publications (1)

Publication Number Publication Date
ATE478964T1 true ATE478964T1 (de) 2010-09-15

Family

ID=35450905

Family Applications (1)

Application Number Title Priority Date Filing Date
AT05745933T ATE478964T1 (de) 2004-05-27 2005-05-27 Sonde zur diagnose von marfans-syndrom sowie verfahren zum screening mit der sonde

Country Status (6)

Country Link
US (2) US20080199856A1 (de)
EP (1) EP1767653B1 (de)
JP (1) JP4706193B2 (de)
AT (1) ATE478964T1 (de)
DE (1) DE602005023160D1 (de)
WO (1) WO2005116253A1 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11692028B2 (en) 2017-03-02 2023-07-04 The Johns Hopkins University Map kinase pathway targets for the treatment of Marfan syndrome
WO2019113123A1 (en) * 2017-12-04 2019-06-13 Precithera, Inc. TGF-ß RECEPTOR FUSION PROTEINS AND OTHER TGF-ß ANTAGONISTS FOR REDUCING TGF-ß SIGNALING
CN109666729A (zh) * 2019-01-29 2019-04-23 四川省人民医院 一种马凡综合征筛查试剂盒
CN109666678A (zh) * 2019-01-29 2019-04-23 四川省人民医院 检测马凡综合征的试剂盒
CN109666676A (zh) * 2019-01-29 2019-04-23 四川省人民医院 筛查马凡综合征的试剂盒
CN114214398B (zh) * 2021-09-26 2022-10-25 百世诺(北京)医学检验实验室有限公司 突变的fbn1基因及马凡氏综合征检测试剂盒
CN114107452B (zh) * 2021-12-07 2022-06-24 深圳市眼科医院 一种基于fbn1基因插入突变的马凡综合征检测试剂盒

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6008011A (en) * 1991-10-31 1999-12-28 Whitehead Institute For Biomedical Research TGF-β type II receptor cDNAs
DE69232986T2 (de) * 1991-10-31 2003-12-11 Whitehead Biomedical Inst TGF-BETA TYP III REZEPTOR, DAFüR KODIERENDE CDNS UND DEREN VERWENDUNG

Also Published As

Publication number Publication date
JP4706193B2 (ja) 2011-06-22
EP1767653A4 (de) 2008-04-16
EP1767653A1 (de) 2007-03-28
EP1767653B1 (de) 2010-08-25
US20100209923A1 (en) 2010-08-19
JP2005333896A (ja) 2005-12-08
DE602005023160D1 (de) 2010-10-07
US20080199856A1 (en) 2008-08-21
WO2005116253A1 (ja) 2005-12-08

Similar Documents

Publication Publication Date Title
ATE478964T1 (de) Sonde zur diagnose von marfans-syndrom sowie verfahren zum screening mit der sonde
ATE550099T1 (de) Verbessertes system für mehrfarbige echtzeit-pcr
GB0523282D0 (en) Methods using pores
ATE488251T1 (de) Verfahren zur diagnose und behandlung von schwangerschaftsskomplikationen
ATE548467T1 (de) Verfahren zur identifizierung von biomarkern mit eignung bei der diagnose biologischer zustände
ATE450623T1 (de) Modifikatoren der lichtemission und ihre verwendungen zur detektion, amplifikation und analyse von nukleinsäuren
ATE478944T1 (de) Zytokin ligand zur behandlung von asthma und atemwegsüberreaktivität
ATE527542T1 (de) Verfahren zur herstellung von abbildungssonden unter verwendung von click chemie
ATE490323T1 (de) Adiponektin-rezeptor und dafür kodierendes gen
ATE392430T1 (de) Verfahren zur herstellung von dipeptiden
NO20070521L (no) Fremgangsmater relatert til en enkel nukleotid polymorfisme av den G-proteinkoplede reseptor, GPR40
ATE535620T1 (de) Entwicklung eines echtzeit-pcr-tests zum nachweis von pneumokokken-dna und diagnose einer pneumokokkenerkrankung
ATE422671T1 (de) Verfahren zur diagnose von morbus alzheimer
ATE545030T1 (de) Testverfahren für nukleinsäurebindendes protein auf biochipbasis
ATE521587T1 (de) Verfahren zur herstellung von (z)-1-phenyl-1- diethylaminocarbonyl-2- aminomethylcyclopropanhydrochlorid
ATE532072T1 (de) Verfahren und vorrichtung zur beurteilung von polypeptidaggregation
ATE480641T1 (de) Zusammensetzungen, reagenzien, kits und verfahren für die diagnose und behandlung von fettleibigkeit und/oder diabetes
ATE394417T1 (de) Sonde zum nachweis von nukleinsäuren
ATE440968T1 (de) Verfahren zur diagnostizierung von aspirinunverträglichkeit
DE60041582D1 (de) Verfahren zum nachweis ungenügender bindung von magnesium an zelluläre membranen zum krankheitsnachweis
ATE527376T1 (de) Pna-sonden, sondensätze, verfahren und kits im zusammenhang mit dem nachweis von candida
ATE275268T1 (de) Verfahren zur diagnose von sjögren-syndrom
ATE432996T1 (de) Verfahren zur bestimmung des bodenzustands
ATE432469T1 (de) Auf immunreaktion gegen boris basierendes verfahren für den nachweis von krebs
ATE335853T1 (de) Verfahren zum nachweis von hybridisierungsereignissen in nukleinsäuren

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties